Growth Metrics

ADC Therapeutics (ADCT) EBT: 2018-2022

Historic EBT for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$154,661.

  • ADC Therapeutics' EBT rose 11.53% to -$45.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$157.8 million, marking a year-over-year decrease of 17.31%. This contributed to the annual value of -$154,661 for FY2022, which is 38.51% up from last year.
  • As of FY2022, ADC Therapeutics' EBT stood at -$154,661, which was up 38.51% from -$251,505 recorded in FY2021.
  • ADC Therapeutics' 5-year EBT high stood at -$115,902 for FY2019, and its period low was -$251,505 during FY2021.
  • Moreover, its 3-year median value for EBT was -$245,963 (2020), whereas its average is -$217,376.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 112.22% in 2020, then soared by 38.51% in 2022.
  • Over the past 5 years, ADC Therapeutics' EBT (Yearly) stood at -$122,872 in 2018, then climbed by 5.67% to -$115,902 in 2019, then plummeted by 112.22% to -$245,963 in 2020, then fell by 2.25% to -$251,505 in 2021, then surged by 38.51% to -$154,661 in 2022.